3
Announcements
Trials
Browse
Landscape
Phase
Phase NA
1
Status
Unknown
1
Terminated
1
Not yet recruiting
1
Sponsor Class
OTHER_GOV
1
Study Type
Interventional
1
Sponsor
Cancer Type
Head & Neck
1
Conditions
Prostatic Neoplasms
4
Neoplasms
4
Esophageal Squamous Cell Carcinoma
3
Breast Neoplasms
3
Stomach Neoplasms
2
Rectal Neoplasms
2
Neuroendocrine Tumors
2
Neoplasm Metastasis
2
Glioma
2
Esophageal Neoplasms
2
Carcinoma, Non-Small-Cell Lung
2
Uterine Cervical Neoplasms
1
Squamous Cell Carcinoma of Head and Neck
1
Recurrence
1
Precursor Cell Lymphoblastic Leukemia-Lymphoma
1
Pathologic Complete Response
1
Neoplastic Cells, Circulating
1
Nasopharyngeal Carcinoma
1
Mouth Neoplasms
1
Metastasis of Unknown Origin
1
Lymphoma
1
Lung Neoplasms
1
Leukemia, T-Cell
1
Leukemia
1
Hypoxia
1
Gynecological Tumors
1
Factors Affecting BAT Activation in PET/CT
1
Endometrial Neoplasms
1
Distant Metastasis
1
Disease
1
Interventions
Cisplatin
22
Radiotherapy
15
Cetuximab
12
Docetaxel
11
Carboplatin
10
pembrolizumab
8
toripalimab
6
camrelizumab
6
Paclitaxel
5
Nivolumab
5
Neoadjuvant Therapy
5
Fluorouracil
5
Drug Therapy
5
Chemoradiotherapy
5
nimotuzumab
4
durvalumab
4
Blood Specimen Collection
4
sintilimab
3
cemiplimab
3
apatinib
3
advexin
3
Surveys and Questionnaires
3
Surgical Procedures, Operative
3
Immunohistochemistry
3
Celecoxib
3
nedaplatin
2
Therapeutics
2
Tegafur
2
Radiotherapy, Intensity-Modulated
2
Methotrexate
2
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Unknown
×
Squamous Cell Carcinoma of Head and Neck
×
Positron Emission Tomography Computed Tomography
×
Clear all
NCT04196985
2021-04-13
HENEPET
Turku University Hospital
Phase NA
Unknown
40 enrolled